California State Teachers Retirement System Sells 3,186 Shares of AptarGroup, Inc. $ATR

California State Teachers Retirement System lowered its holdings in shares of AptarGroup, Inc. (NYSE:ATR - Free Report) by 4.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 74,041 shares of the industrial products company's stock after selling 3,186 shares during the period. California State Teachers Retirement System owned approximately 0.12% of AptarGroup worth $9,269,933 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in ATR. BlackRock Inc. purchased a new position in shares of AptarGroup during the second quarter valued at about $768,464,000. Victory Capital Management Inc. increased its holdings in AptarGroup by 4.0% in the 4th quarter. Victory Capital Management Inc. now owns 2,291,454 shares of the industrial products company's stock worth $279,466,000 after buying an additional 88,717 shares during the period. Geode Capital Management LLC increased its stake in AptarGroup by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 1,618,896 shares of the industrial products company's stock worth $197,473,000 after buying an additional 15,197 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of AptarGroup by 15.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,504,473 shares of the industrial products company's stock worth $189,581,000 after purchasing an additional 203,672 shares during the last quarter. Finally, Fiduciary Management Inc. WI grew its holdings in AptarGroup by 9.2% during the 4th quarter. Fiduciary Management Inc. WI now owns 1,247,557 shares of the industrial products company's stock worth $152,152,000 after acquiring an additional 104,667 shares in the last quarter. 88.52% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ATR has been the subject of several research analyst reports. Raymond James Financial reaffirmed an "outperform" rating and set a $160.00 price target on shares of AptarGroup in a research report on Wednesday, July 15th. Wells Fargo & Company increased their price target on shares of AptarGroup from $145.00 to $155.00 and gave the company an "overweight" rating in a research note on Monday, August 3rd. Weiss Ratings reiterated a "hold (c)" rating on shares of AptarGroup in a research note on Wednesday, June 24th. Finally, Bank of America upgraded shares of AptarGroup from a "neutral" rating to a "buy" rating and set a $173.00 price target on the stock in a report on Tuesday, July 14th. Five equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $172.80.

AptarGroup Stock Performance

ATR traded down $0.85 on Tuesday, reaching $124.06. 185,457 shares of the stock were exchanged, compared to its average volume of 492,123. AptarGroup, Inc. has a fifty-two week low of $103.23 and a fifty-two week high of $146.91. The firm has a market capitalization of $7.89 billion, a PE ratio of 22.42, a PEG ratio of 3.19 and a beta of 0.38. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.61 and a quick ratio of 1.10. The company's 50-day moving average price is $131.05 and its 200 day moving average price is $126.60.

AptarGroup (NYSE:ATR - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The industrial products company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.35 by $0.07. AptarGroup had a return on equity of 13.31% and a net margin of 9.22%.The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.01 billion. During the same quarter in the prior year, the business earned $1.66 EPS. AptarGroup's revenue was up 6.3% on a year-over-year basis. AptarGroup has set its Q3 2026 guidance at 1.450-1.530 EPS. As a group, sell-side analysts forecast that AptarGroup, Inc. will post 5.48 EPS for the current fiscal year.

AptarGroup Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Stockholders of record on Thursday, July 30th were issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend was Thursday, July 30th. AptarGroup's dividend payout ratio (DPR) is presently 34.72%.

Insider Activity at AptarGroup

In other AptarGroup news, CEO Gael Touya sold 3,740 shares of AptarGroup stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $133.76, for a total transaction of $500,262.40. Following the completion of the transaction, the chief executive officer owned 29,102 shares in the company, valued at approximately $3,892,683.52. The trade was a 11.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Stephan B. Tanda sold 9,838 shares of AptarGroup stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.16, for a total transaction of $1,339,542.08. Following the sale, the chief executive officer owned 238,729 shares of the company's stock, valued at approximately $32,505,340.64. The trade was a 3.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 23,197 shares of company stock valued at $3,134,828 over the last ninety days. Company insiders own 0.73% of the company's stock.

AptarGroup Company Profile

AptarGroup, Inc is a global supplier of dispensing, packaging and drug-delivery solutions. The company develops and manufactures pumps, valves, aerosol systems, closures, dispensing devices and other components used to package and deliver products in the pharmaceutical, beauty, personal care, food and beverage markets.

Its pharmaceutical offerings include nasal, respiratory, ophthalmic and dermal drug-delivery systems, as well as components and technologies designed to support the administration of prescription and consumer healthcare products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.